New centre targets ‘undruggable’ cancers after major donation 03 Apr 2022 The centre will focus on ‘targeted protein degradation’ – one of the hottest and most promising areas in drug discovery. Scientists aim to hijack normal process of protein destruction to wipe out cancer proteins that traditional targeted drugs cannot block. Find out more Show/Hide
Monte Rosa Therapeutics lists on New York Stock Exchange 10 Sep 2021 Monte Rosa Therapeutics, a biotechnology company originally formed as a spinout from science at The Institute of Cancer Research, London, partly funded by Cancer Research UK, is now listed on the Nasdaq stock exchange in New York. Find out more Show/Hide
ICR experts show Discovery Club how to build the cancer drugs of the future 24 Feb 2020 Members of the ICR’s Discovery Club saw first-hand the delicacy and complexity of techniques used to sculpt new drug molecules, as they learned how our scientists design the cancer drugs of the future. Find out more Show/Hide